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The CRISPR/Cas9 system has been adapted into a powerful tool for genetic research. The ability 
to target regions of a genome in a highly specific manner with a reprogrammable guide RNA has been used 
in a variety of applications. These applications include targeted double stranded breaks for inducing 
mutations or gene knock-ins, as well as hijacking the targeting ability of CRISPR/Cas9 to guide proteins to 
a defined sequence within the genome. These methods have been established in multiple model organisms 
including Drosophila. Since the establishment of the Drosophila model organism in 1909, methods have 
been discovered and refined to allow researchers to lay the groundwork for our understanding of eukaryotic 
genetics. This thesis evaluates two methods that combine previously established techniques found in the 
Drosophila toolbox with the CRISPR/Cas9 system and its modifications. The first is an F1 visible screen 
for loss-of-function mutations utilizing overexpression methods adapted from CRISPR/Cas9 technology. 
The second method attempts to evaluate the efficiency of creating translocations with CRISPR/Cas9 using 
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Background development of CRISPR/Cas9 
1.1 Drosophila as a Model Genetic Organism 
The species Drosophila melanogaster has been established as a key model organism for researching 
eukaryotic genetics. Since 1909 Drosophila have been used for their high fecundity and low cost. This 
organism has become a cornerstone of modern genetics (Hales et al., 2015). It takes roughly 10 days for an 
egg to develop into a mature adult fly (Hales et al., 2015). The developing embryo is an excellent model 
for developmental biology. Many of the processes typical of generalized body development; segmentation, 
specification of body axes are readily observed in Drosophila (Duffy, 2002). Moreover, using the genetic 
toolbox available for Drosophila, mutations disrupting these processes can be isolated and maintained as 
balanced stocks (Hales et al., 2015). In the late 1980’s it was the ability to isolate mutations, and ultimately 
map, clone and sequence the genes associated with particular mutants that led to a major breakthrough in 
the field of animal development (Hales et al., 2015).  
After the Drosophila genome was sequenced in 1999 and compared the sequenced human genome 
in 2000, it was estimated that 75% of known human diseases genes have orthologues in Drosophila (Pandey 
& Nichols, 2011). This makes Drosophila a great model  organism for modeling the function of these human 
disease genes. At this point the power of Drosophila as a model organism is due in part to the history of 
Drosophila genetics. Drosophila has a storied history of contributions to modern genetics. In addition to the 
proof of the chromosomal theory of inheritance (Bridges, 1919), it was through Drosophila that we learnt 
that X-rays are mutagenic (H. Muller, 1928). More recently HOX genes which are the main genes that 
control body segment, in all metazoans were discovered in Drosophila (McGinnis et al., 1984). 
Throughout the years different technologies have been implemented in Drosophila to further our 
understanding of eukaryotes. Earliest technologies included random mutagenesis to determine gene 




resolution physical map of the genome in the form of the salivary gland polytene chromosomes (Zhimulev 
& Koryakov, 2009). These chromosomes are formed through endoreduplication cycles of repeated DNA 
replication without mitosis, and up to 1000 copies of interphase chromatids remain aligned forming a highly 
reproducible banding pattern (Zhimulev & Koryakov, 2009). In addition, these polytene chromosomes are 
paired with their homologues, which enables easy identification of large scale chromosomal rearrangements 
(Zhimulev & Koryakov, 2009).  
In addition to these polytene chromosomes, one of most powerful genetic tools used in Drosophila 
are balancer chromosomes. Balancer chromosomes are ultimately useful for the maintenance of mutations 
as heterozygotes (Hentges & Justice, 2004). Balancers achieve this by containing multiple inversions and 
these inversions have two effects (Hentges & Justice, 2004). First, they disrupt pairing of homologues 
during meiosis and supress meiotic recombination (Hentges & Justice, 2004). Second, if there is successful 
pairing and a meiotic recombination event, which invariably will occur within an inverted region of a 
paracentric or pericentric inversion, the products will either result in dicentric or acentric chromosome 
fragments and/or be excessively aneuploid (Hentges & Justice, 2004). Through the suppression of meiotic 
recombination, a chromosome carrying a recessive lethal is not lost through recombination with the 
homologue in the case where the balancer chromosome carries a second unlinked recessive lethal mutation 
(Hentges & Justice, 2004). These chromosomes also carry a dominant visible marker that allows the 
chromosome to be followed within a population. By using balancer chromosomes, any mutation, including 
recessive lethal mutations, can be maintained as a heterozygous stock. This facilitates further genetic and 
phenotypic analysis. Indeed, it is noteworthy that the famous saturation mutagenesis screens for embryonic 
lethal mutations performed in the 1980’s by Christiana Nusslein-Volhard and Eric Weischaus would not 




With the advent of molecular biology Drosophila genetics continued to acquire new and powerful 
tools. These include single P element mutagenesis (transposon tagging), and the development of modified 
transposons for transgenesis as well as enhancer trap analysis of gene expression (Bier et al., 2018). In 
addition, systems of inducible gene expression as well as somatic recombination have been developed, 
permitting analysis of ectopic gene expression and genetic mosaic analysis, respectively (Bier et al., 2018). 
The Drosophila research community has a long history of collaboration and the database FlyBase was 
created in 1992 as a hub for consolidating information on the fly genome (Drysdale et al., 2005). 
The most used system of inducible gene expression in Drosophila is known as the GAL4/UAS 
system (Duffy, 2002). This tool, which was “imported” to Drosophila from yeast, consists of the GAL4 
transcription factor and the upstream activation sequence (UAS) (Duffy, 2002). GAL4 can be expressed in 
various cell types and areas of Drosophila which can then be used to upregulate any sequence that has a 
UAS sequence attached up stream of the transcription start site (Duffy, 2002).  
 Unlike mammalian systems and yeast, Drosophila does not readily undergo homologous 
recombination and as such the advantages of specific gene knock-out or specific gene replacement 
strategies has been a shortcoming of Drosophila as a model genetic system (Hales et al., 2015). Only 
recently, targeting specific parts of the genome became a reality with the introduction of zinc finger 
nucleases (ZFNs) and TALENs (Ma & Liu, 2015). However, these technologies need to be specifically 
manufactured for each use and are labour intensive. All of this has recently changed with the introduction 
of CRISPR/Cas9 genome editing, which allows for quick and specific targeting of any point within the 
Drosophila genome (Bassett et al., 2013). CRISPR/Cas9 is now routinely used and is the method of choice 
for generating mutations or facilitating gene replacement in Drosophila and many other model genetic 




In the short time since the CRISPR/Cas9 system was introduced, there have been numerous 
modifications to the system for use in Drosophila. The first of these was implemented in 2013 showed that 
it was possible to adapt the CRISPR/Cas9 system for Drosophila. This was first done by using plasmids 
containing Cas9 and a guide RNA (gRNA) for the yellow gene. Mutagenesis occurred in 5.9% of progeny 
(Bassett et al., 2013). Although rates were low it showed promise for the technique. The next major 
advancement happened when researchers transformed embryos to produce in vivo transcribed Cas9 and 
gRNAs with mutagenesis rates as high as 42.9% (Lin et al., 2015). 
 The purpose of this thesis was to explore the use and limitations of CRISPR/Cas9 genome editing 
for two genetic applications in Drosophila. By combining CRISPR/Cas9 technology with other Drosophila 
based tools that have been developed over multiple decades, we have been able to test the usage and 
limitations of CRISPR/Cas9 as a genetic tool.  
1.2 Development of CRISPR/Cas9 as a Genetic Tool 
Clustered regularly interspersed short palindromic repeats (CRISPR) are repeat regions of DNA 
that were first discovered in Streptococcus thermophiles (Bolotin et al., 2005). Their true function would 
not be deduced until 2005 when multiple research groups made the realization that sections in this CRISPR 
locus are associated with various viruses and archaea (Pourcel et al., 2005). Within what are called the 
spacer regions of the CRISPR locus, DNA sequences with direct homology to plasmids, bacteriophages 
and prophages were identified. Furthermore, hosts that contained sequences homologous to a particular 
phage or plasmid were immune to infection.  By integrating part of invading DNA into the CRISPR locus, 
the organism can recognize the same viral threat. With this stored information, CRISPR-associated genes 
(Cas) complexed with RNA form an endonuclease that creates double-stranded breaks (DSBs) in the 
foreign DNA, effectively neutralizing it (Bolotin et al., 2005). In order to recognize the viral DNA threat, 




This Cas RNA complex binds using the RNA, which is transcribed from the stored sequences within the 
spacer regions of the CRISPR locus, as a template to target foreign DNA degradation (Bolotin et al., 2005). 
In 2007 it was discovered that the CRISPR locus functions as a form of adaptive immunity in 
bacteria (Barrangou et al., 2007). A strain of Steptococcus thermophillus had sections of a phage sequence 
integrated into the CRISPR locus as a template to target foreign DNA for degradation (Barrangou et al., 
2007). The modified strain was then shown to be immune to infection by phage, proving the hypothesis of 
acquired immunity. Subsequently, in 2008 sections of the CRISPR locus were found to be directly derived 
from phages. These sequences, usually about 20 bps in length, were found to be transcribed into RNAs and 
were termed CRISPR RNAs (crRNAs). These crRNAs were found to act as guides when combined with 
Cas proteins, leading to endonuclease activity and the creation of DSBs at sites homologous to the crRNA 
sequence (Brouns et al., 2008). While several different CRISPR/Cas systems have been discovered, it has 
been predominantly the Cas9 protein from Steptococcus pyogenes that has been developed as a tool for 
genome editing. This is due, in part, to the discovery 2010 that Cas9 was sufficient for targeted 
endonuclease activity (Garneau et al., 2010). The last major component in the system was found to be a 
trans-activating CRISPR RNA (tracrRNA) which complexes with crRNA in order to guide Cas9 to a target 
(Deltcheva et al., 2011). 
In 2012 the full mechanism for how the CRISPR system works was elucidated. In order for target 
sequences to be cleaved by the Cas RNA complex, it was found that targets had to be associated with 
protospacer adjacent motif (PAM) which is found in the target sequences but not in the gRNA itself 
(Gasiunas et al., 2012). In this way, it is the presence of the PAM that permits the bacterial adaptive immune 
system to distinguish self from non-self. For the Cas9 system, the PAM is the sequence “NGG” although 
multiple different Cas proteins use different PAM sequences (Gasiunas et al., 2012). For Cas9, this is a 




the crRNA could also be shortened to 20 nucleotides in order for cleavage to take place and more 
importantly this sequence can be changed to allow Cas9 to cut at different sites (Gasiunas et al., 2012). 
Also, it was found that the tracrRNA and crRNA could be fused and that could be transcribed as a single 
RNA molecule known as guide-RNA (gRNA). Subsequently this system was refined to the engineered 
minimal 2-part system that is the most widely used genome editing (gRNA +Cas9) (Jinek et al., 2012).  
1.3 Generalized Uses of Engineered CRISPR/Cas9 
As an engineered genome editing technique, the initial common application for this tool was to 
create DSBs. What’s more revolutionary is that as long as Cas9 and gRNAs can be introduced into a model 
system the corresponding DSBs can be created in a highly specific manner. Off-site targeting is also rare 
due to the long and very specific 20bp guide (Jinek et al., 2012). These targeted DSBs are repaired using 
imprecise cellular machinery. This has a wide variety of applications, including creating mutations in the 
given target sequence through non-homologous end joining (NHEJ) and the incorporation of template 
strands into genomic DNA through homology-directed repair (HDR) (Bier et al., 2018). 
One of the more obvious applications of the CRISPR/Cas9 system is a gene knock-in. This can be 
done easily using Cas9, a gRNA that targets a sequence at which the knock-in should take place, and an 
oligonucleotide that has areas of homology to the target sequence flanking the desired knock-in sequence 
(Ma & Liu, 2015). In this approach repair of the targeted DSB by HDR using the provided oligonucleotide 
as a template is an efficient method for gene replacement. Methods of delivery can vary depending on the 
model organism used and might include lipid-mediated transfection, microinjection or electroporation 
among others. 
The CRISPR/Cas9 system has been further engineered using a number of different modifications. 
The basic idea of some of these modifications is to utilize the ability of Cas9 to be directed to a sequence 




specified sequence. Such a modified Cas9 does not have any nuclease activity and is referred to as a dead 
Cas9 (dCas9) (Qi et al., 2013). One such application has been the design of DNA base editors. In this case 
dCas9 is augmented with a ribonuclease protein complex that creates a single base substitution when 
targeted to a sequence of interest.  
Another application of dCas9 is used when investigating the composition of chromatin (Fujita & 
Fujii, 2013). Using DNA-binding molecule-mediated Chromatin immunoprecipitation (enChIP) it is 
possible to tag a region of interest by having a FLAG-tagged dCas9 targeted to a genomic area of interest. 
These fragments can then be isolated via FLAG-tag specific antibodies and put through mass spectrometry 
(Fujita & Fujii, 2013). This allows for the identification of proteins that are associated with specific loci. A 
similar process to this is known as CasID, where dCas9 is fused with promiscuous biotin ligase BirA* 
(Schmidtmann et al., 2016). Biotin is then added to the system which results in proteins near (~10nm) the 
loci to which dCas9 was targeted to being tagged with biotin (Schmidtmann et al., 2016). These tagged 
proteins can also be isolated and identified by mass spectrometry.  
The CRISPR/Cas9 system has also been adapted to repress gene transcription. This was first done 
in E.coli with a system called CRISPR interference (CRISPRi). In this case, a dCas9 physically blocks 
transcription from initiating (Bier et al., 2018). It can also be used to bind the cis element targets of specific 
a transcription factor, thus blocking its activity. This was later refined by adding a repressor domain to 
dCas9 called Kruppel-associated box (KRAB) (Bassett & Liu, 2014).  
Another application of dCas9 is to overexpress targeted genes of interest. This is done by fusing it 
to a transcriptional activation domain consisting of VP64, p65 and Rta domains (VPR) (Lin et al., 2015). 
Altogether, this dCas9VPR has no nuclease activity but has the ability to upregulate the transcription of a 
gene of interest if the gRNAs are targeted to a sequence in the proximity and usually upstream of any given 




Examples of using the CRISPR-Cas9 system to impart immunity have been reported (Sapranauskas 
et al., 2011). By integrating a section of DNA specific to antibiotic resistant bacteria to a CRISPR loci, it is 
possible to allow Cas9 to target these sections of invasive genomes. Not only is this a method of effectively 
eliminating antibiotic resistant bacteria, if the target sequence is specific enough the system will only 
destroy the target bacteria leaving non-resistant bacteria alone.  
1.4 Using CRISPR in Humans 
In a medical context, the use of CRISPR to cure human disease has been of great interest. The 
concept of gene therapy is not a new one. Using various viruses as a vector to transform cells that would 
otherwise have certain pathologies has been done before in humans. The concept of such a therapy goes 
back to the 1970’s (Friedmann & Roblin, 1972). Although there have been numerous breakthroughs in the 
field, the introduction of the CRISPR-Cas9 system is of special note. The ability to rapidly target and create 
DSBs in a gene of interest and subsequent repair using HDR could open doors for possible therapies.  
Many human pathologies could be cured with an edit to a single gene. As a proof-of-principle it 
has been shown in mice that injecting a zygote with Cas9 mRNA, sgRNA and an oligonucleotide with 
homologies to the desired sequence and correction for the gene of interest is enough to cure mice of cataracts 
caused by the gene crystalline gamma c (Savić & Schwank, 2016). This method proves effective in curing 
a disease prenatally. The use of CRISPR to cure pathologies postnatally has been researched as well. In 
2016 scientists at Sichuan University’s West China Hospital began human trials involving CRISPR. This 
trial involves taking patient cells and knocking out the PD-1 gen which is responsible for slowing the 
immune response. Then re introducing the transformed cells back into the patient. There are even treatments 
that have finished trial periods and are available to the public. A cure for spinal muscular atrophy has been 
engineered with the help of CRISPR/Cas9 in humans. The cure itself is called Zolgensma is a single 





Development of an F1 Visible Screen for Loss of Function Mutations 
Using dCas9VPR 
2.1 Introduction 
 CRISPR/Cas9 has been used for several applications in the model genetic organism Drosophila. 
First and foremost, CRISPR/Cas9 has been used to create DSBs when guided to a sequence of interest 
based on a designed gRNA. This can result in mutations in a sequence of interest producing small insertions 
or deletions due to non-homologous end joining (NHEJ) (Matsumoto et al., 2020). Moreover, when an 
oligonucleotide is introduced that contains sequences homologous to the sequences flanking the guide target 
sequence, integration of the said oligonucleotide into the genome can occur through HDR (Matsumoto et 
al., 2020). Other applications of the CRISPR/Cas9 system in Drosophila have been developed, including 
converting Cas9 to a transcriptional activator. This is done by mutating the catalytic sites of the Cas9 
endonuclease effectively rendering it unable to make DSBs. Such a catalytically inactive Cas9 is known as 
dead Cas9 (dCas9) (Lin et al., 2015). This dCas9 has been further modified by fusing it to domains that can 
activate transcription. This is the VPR transcriptional activation domain and the resulting fusion protein is 
known as dCas9VPR (Lin et al., 2015).  
 The expression of dCas9VPR under the control of the Gal4 system, permits overexpression of 
endogenous genes through co-expression of a specific gRNA in a tissue specific manner. There are 
currently more than 1600 transgenic stocks that express different gRNAs under a ubiquitin promoter. A 
publicly available resource for such purposes is the TRiP transgenic stock collection from the Bloomington 
Drosophila Stock Center. While some of these stocks have been designed for targeted gene knock down 
(these are known as TRiP-KO lines or TKO lines), others have been designed for targeted overexpression 




TOE lines and express 2 gRNAs that are targeted to regions upstream of a gene’s transcriptional start site 
(TSS)(Zirin et al., 2020). By combining TOE lines with the UAS-dCas9VPR and a Gal4 driver it is possible 
to over express a gene of interest in a tissue specific manner. This approach of ectopic gene expression or 
gene overexpression differs from the traditional Gal4/UAS method in that the GOI that is being 
overexpressed is an endogenous allele.   
2.1.1 Hindsight 
The gene hnt encodes the C2H2 zinc finger transcription factor, Hindsight, that is required at 
multiple times and in multiple tissues during Drosophila development. The Hnt protein is 1893 amino acids 
in length and includes 14 C2H2 zinc finger domains (Wilk et al., 2000). Processes known to require HNT 
include germ band retraction and maintenance of the extraembryonic membrane known as the amnioserosa, 
tracheal formation, and differentiation of the pupal retinal epithelium (Farley et al., 2018). The gene hnt 
also has a human homologue called Ras-Responsive Binding Element 1 (RREB-1), which has been 
implicated in a number of human pathologies such as thyroid, colorectal and pancreatic cancer (Farley et 
al., 2018). As a proof of principle for this new screening strategy, we aimed to be able to quickly recover 
numerous new alleles of hnt with the expectation that some of these new alleles may shed some light on 
the function and regulation of this important gene.  
Using this new system of gene overexpression we were examining the phenotypes associated with 
overexpression and ectopic expression of hnt. Similar to previous observations of hnt overexpression using 
the Gal4/UAS system, we found that dCas9VPR based overexpression results in the disruption of the 
development of the compound eye. Unlike the Gal4/UAS system for hnt overexpression, however, the 
severity of this phenotype when using the dCas9VPR proved to be sensitive to the number of functional hnt 
alleles. Based on this observation we found that dCas9VPR overexpression could be used as a basis for 




2.1.2 Background of the Development of a System to Overexpress hnt using dCas9VPR 
The following components are needed for targeted overexpression in the Drosophila eye using the 
VPR-based overexpression system. The first component is the glass mediated response element (GMR), 
which drives GAL4 expression in the developing eye imaginal disc (Li et al., 2012). The next component 
is the dCas9VPR with controlled expression due to an upstream UAS. The third and final component is the 
TOE-GS00052 transgene which ubiquitously expresses two guide RNAs that target sequences directly 
upstream of hnt (183-203 and 110-129 bp from the transcription start site respectively). In this system, 
GAL4 is expressed in the developing eye imaginal disc which then activates the expression of UAS-
dCas9VPR. This causes overexpression of hnt due to the ubiquitously expressed TOE-GS00052. The 
overexpression of hnt through this method is temperature sensitive: when a homozygous wildtype hnt allele 
is subjected to this system at 25˚C, it leads to lethality due to the overexpression of hnt. However, the same 
genotype is viable at 18˚C because the GAL4/UAS system is well-known to be temperature sensitive and 
more efficient at 25˚C (Duffy, 2002). At 18˚C, the dCas9VPR mediated overexpression of hnt results a visible 
phenotype (Figures 2-1 and 2-2), which comprises a red ring around the eye and drastic developmental 





Figure 2-1 Overexpression of hnt in the developing eye disrupts eye formation in a temperature and 
dosage sensitive manner 
(A) Shows proximity of target sequences of TOE-GS00052 to transcription start site of hnt (B) Wildtype 
eye (C) Eye under overexpression of hnt showing GMR-Gal4 >  UAS-GFP-Hnt127. (D) When a hnt null 




due to having fewer hnt copies to overexpress. (E) Overexpression phenotype of TOE-GS00052 with GMR-
Gal4 > UAS-dCas9VPR. (F) Supressed phenotype of (E) with co-expressed UAS-hnt-RNAi 
  
Heterozygotes for different hnt alleles were crossed into this background of dCas9VPR mediated 
overexpression. The following experiments were performed by Dr. Reed. The allele hntXE81 is a 
nullomorphic allele which does not produce functional Hnt. Interestingly hntXE81 is viable at 25˚C, but 
produced the same phenotype as seen at 18˚C in the overexpression background. A deletion of the hnt 
region was also viable at 25˚C resulting in the same phenotype as hntXE81. Another lethal hnt allele, hntPL67, 
resulted in lethal overexpression in this system, indicating that this allele does not disrupt the region 
including the gRNA target sequences or the protein coding sequence of the hnt gene.  Overall, this ability 
to overexpress mutant alleles represents a novel approach for characterizing alleles which is similar to the 
traditional Mullerian system of allele classification (H. J. Muller, 1932). 
We propose a novel screening strategy in which randomly induced mutations in hnt could be 
selected using an F1 visible screen. 
2.2 Methods 
2.2.1 Single Fly Genomic DNA Extraction 
The extraction of whole genomic DNA from a single male fly was done through the following 
procedure. The fly was suspended in 150µl of squish buffer containing 1M Tris-Cl pH 8.0, 100 mM EDTA, 
5M NaCl and 5M proteinase K. The fly was then subsequently squished to release its genetic material, 
followed by an incubation at room temperature for 20 minutes to remove some protein from the final 
product. The mixture was incubated at 95˚C for 5 minutes. The solution was diluted to 20ng/µl of DNA. 
Samples to be sequenced included 10µl of the DNA solution and 5µl of custom primers at a concentration 




2.2.2 Single Fly PCR 
PCR primers were designed to amplify the region surrounding the TOE-GS00052 target sequences 
(Appendix B). By using a series of PCR reactions, the integrity of the guide regions were evaluated by 
amplifying the region between the two primers and comparing the amplified sequence to the wildtype. This 
approach was used to verify disruptions within or surrounding the guide target regions associated with 
newly recovered refractory chromosome. Direct PCR sequencing was performed to confirm that refractory 
chromosomes contained disruptions or deletions within the gRNA target sequences. Samples for PCR were 
prepared with 25µL FroggaBio 2X PCR Master mix Solution, 2.5µL of both forward and reverse primers 
at 100M, 2.5µL of sample DNA and 17.5µL of dH2O. Using a thermocycler the samples were subjected to 
the following program: 
1. 94˚C for 3 minutes 
2. 94˚C for 45 seconds 
3. 55˚C for 30 seconds 
4. 72˚C for 1 minute and 30 seconds 
5. Repeat steps 2-4 35 times 
6. 72˚C for 10 minutes 
7. 4˚C hold 
2.2.3 EMS Mutagenesis 
Adult males of various ages with the genotype y w P[w+]e02388b/Y were starved for 8 hours. A 
solution containing 3mL of a 1% sucrose solution in dH20 and 0.025M EMS from Sigma-Aldritch, was 
prepared. Parafilm was added over the vessel to prevent splashing of EMS. An 18-gauge needle was then 




mixture to create an emulsion. A 1L incubation vessel was then prepared with a single layer of kimwipes 
and the EMS solution was added until the kimwipe was thoroughly soaked through. Male flies were added 
to this vessel and allowed to feed on the EMS laced sugar solution for 24h. Flies were used in crosses 
immediately following this 24h period. Culture vessels and kimwipes were decontaminated in 10% solution 
of W/V sodium thiosulfate for 24h to deactivate EMS. 
2.2.4 Complementation Tests 
Newly derived hnt alleles were balanced using FM7h (Ashburner, 1989) and balanced females were 
crossed to hntpeb males. hntpeb is a temperature sensitive visible allele of hnt that is associated with a rough 
eye phenotype when reared at the restrictive temperature of 29˚C (Ashburner, 1989). If the putative new 
allele failed to complement hntpeb, (i.e., meaning that at 29˚C a rough eye phenotype was observed), then 
the new allele was deemed to be a true new allele of hnt.   
2.2.5 Sequencing hnt REF alleles 
Sequencing of the PCR fragment containing the TOE-GS00052 target site was done by the London 
Regional Genomics Centre. Genomic DNA samples were amplified using primers that flanked the target 
site following the PCR methods outlined in Section 2.2.2. Samples were then purified through spin columns 
(Manufacturer) and diluted to 20ng/µL based on a nanodrop reading. The same primers that were used in 
the PCR reaction were diluted to 20µM in dH2O and used for the sequencing. In each reaction, 10µl of the 
diluted PCR product and 5µl of the diluted primer were added to a microfuge tube and sent to the London 
Regional Genomics Center for sequencing. Two sets were sent out per sample, one with the forward primer 
of the PCR reaction and another of the reverse. This provided a means to verify the sequence and obtain a 




2.2.6 Immunostaining and Imaging 
PBS 10X solution was prepared with 1.3M NaCl, 70mM Na2HPO4.7H20 and 30mM K2HPO4 in 
dH20. Embroys that were 0-18 hours old were washed in PBS-TX (1X PBS containing 0.12% Triton X-100 
v/v) and collecting them in filtration baskets made with 2000 micron nylon mesh. These baskets were made 
by cutting a 50mL Falcon tube in half width wise and removing the top of the cap. With this setup the mesh 
can be placed between the opening of the Falcon tube and the modified screw cap and thus be removed 
easily without disturbing embryos in the basket. These embryos were then suspended in a 50% commercial 
bleach and PBS-TX solution to dissolve the outer cuticle. The embryos were then fixed with formaldehyde 
in a 3.7% solution in 1X PBS (w/v) over which there was an equal volume of heptane for 20 minutes. Lower 
aqueous fixative layer was carefully removed and replaced with methanol. With vigorous shaking, 
devitalized embryos settled to the bottom of the methanol phase. The embryos were then carefully removed 
and rehydrated with a methanol series. Starting with 75% methanol to PBS by volume, each sample was 
suspended in solution and allowed to settle to the bottom of the tube. This process was repeated, decreasing 
the methanol percentage by 25% until embryos were submerged in 1X PBS. 
 Blocking solution was prepared using a PBS-TX solution with 2.5% bovine serum albumin (BSA) 
and 5% normal goat serum (Thermo Fisher Scientific 31872). The embryos were thoroughly washed and 
blocked for 1 hour after which the blocking agent was removed. The following antibodies were applied at 
the indicated dilutions: mouse monoclonal anti-Hnt 27B8 1G9 (1:10; from H. Lipshitz, University of 
Toronto) along with guinea pig polyclonal anti-Hindsight (1:1500; from H. Lipshitz, University of 
Toronto). Antibodies were removed and blocking agent was re-applied for 1 hour. Secondary antibodies 
used were: Alexa Four 488 goat anti-mouse (Cedarlane Labs) and TRITC goat anti-guineapig (1:500: 




Micrographs were taken using a Nikon SMZ25 stereomicroscope equipped with Nikon Digital 
Sight Ri2 16.52 MP colour camera and processing was done using Nikon NIS-Elements Arv4.50 software 
(Figure 2-2. BC). Light microscopy images were taken using a compound Olympus microscope with a 5X 
objective (Figure 2-2. EF). The subject was manually focused on and images were taken to create slices 
which were then processed using ImageJ and an extended depth of focus plugin (Schneider et al., 2012). 
2.3 Results 
The following presents the proof-of-principle screen showing the recovery of loss-of-function 
mutations in hnt selected through an F1 screen. The section immediately below describes the various steps 
and crossing strategies involved in the development, execution and analysis of the results of this screen.   
2.3.1 Creation of the Refractory Chromosome 
The goal of this screening technique is to use dCas9VPR mediated overexpression for the selection 
of multiple hnt null or deficient mutants in an F1 visible screen. Due to the lethality of the overexpression 
at 25˚C, in order to better facilitate this screen, we selected chromosomes that were refractory to the Cas9 
mediated overexpression. The first step was to render the guide target sequences unable to bind to the TOE-
GS00052. To do this, we substituted the dCas9VPR for active Cas9 in the overexpression background. This 
causes the guide target sequences to induce mutations in the target sequences so they are unresponsive 
(refractory) to the TOE-GS00052 and cannot be targeted by the overexpression system. We then combined 
all these elements into a single line that contains the refractory chromosome, gRNAs, GMR-GAL4 and 
UAS-dCas9VPR element; this line is referred to as the RGV line. The steps of this process are shown in 





Figure 2-2 Creation of the Refractory Chromosome 
Crossing scheme used in order to create refractory chromosome. Two lines were sequenced comparing 
them to the wildtype. Refractory stock was created and then crossed to have the UAS-dCas9VPR as well as 
the GMR-Gal4 and the TOE-GS00052. 
2.3.2 F1 Visible Screen 
Adult males of various ages mutagenized with EMS were crossed to virgin RGV females. The 
progeny were screened for the complete absence of the overexpression phenotype. A “hit” in the screen 




were then crossed to the RGV stock to verify that the mutation propagated through the next generation in a 
predictable way. All lines generated through this method also underwent complementation testing to 
determine which were new hnt alleles. The EMS-treated males carried the markers y w P[w+]e02388b. The 
P[w+]e02388b insertion is tightly linked to hnt, being inserted ~ 40Kb from the hnt coding region and is 
associated with the distinctive pattern of w+ expression in the posterior eye. The P[w+]e02388b served as 
a marker for isolation of the mutagenized chromosome and the establishment of isogenic stocks balanced 
over FM7h (Figure 2-3). 
2.3.3 Resulting Progeny from Screen 
After crossing virgin RGV females to EMS-mutagenized males, a total of ~45,000 progeny were 
scored. This was done over a period of 3 weeks with the help of Dr. Reed. Of these progeny 39 females 
were isolated that did not produce an over-expression phenotype. All of these females had a characteristic 
wild-type eye as illustrated in Figure 2-3, which was a striking and easily scorable phenotype in the 
background of the hnt overexpression phenotype (Figure 2-2). Of these females, 15 bred true and were 
established as stocks over FM7h,w. These stocks were then re-tested by crossing to RGV to make sure they 
continued to show a lack of overexpression. After re-testing, 8 of the previously 15 lines were found to be 
true hnt alleles based on complementation tests. The remaining 7 lines were sequenced to elucidate their 
refractory nature and were described as hntREF. Such refractory alleles are somewhat unusual in the system 
of Drosophila nomenclature as their only describable phenotype is that they are unresponsive to this 





Figure 2-3 Visible Screen for loss of function Mutation Strategy 
Virgin female RGV stocks were crossed to EMS mutagenized males. Resulting progeny are either 
responsive to overexpression or are not responsive and thus have wildtype eyes. Wildtype eyes contain the 
presumptive mutation that induces a loss of function allele. These flies were then bred into lines and kept 
balanced over FM7h,w. These were later established as 15 stocks 8 of which were true hnt alleles and 3 
were new refractory hnt alleles. 
2.3.4 Characterization of new hnt alleles 
 Of the 15 stocks that were recovered, 8 were hnt alleles and 7 were refractory chromosomes. The 
target regions of the new refractory lines were amplified using PCR and sequenced (Figure 2-4). Of note 




hntRef-BHR7 was found to contain an A to T base pair change in the first sgRNA target (Figure 2-4). The allele 
hntRef-BHR7 was found to be unusual in that it can over-express hnt in males but not in females. All other 
alleles were found to contain an identical deletion which spans between and including parts of both sgRNA 
target sequences making them refractory. 
 
Figure 2-3 Sequencing results of new Refractory lines 
Sequences of the area between TOE-GS00052 cut sites (underlined) were aligned with the wildtype 
reference sequence. Of note hntREF-BHR7 and hntREF-WN72 both have single base pair changes that render the 
sequence refractory. The latter having it in its PAM motif. The rest have an identical deletion with both 
PAMs missing.  
 
 The newly recovered confirmed alleles were crossed to peb/Y; Ubi-DEcadherin-GFP in order to 
visualize and quantitate the defect in eye development. By quantifying the number of cone cells within each 
ommatidium of the compound eye, these new alleles were ordered into an allelic series according to the 
severity of the defect (Figure 2-5E). The allelic series was created by Molly Chen. Some of these 
ommatidium contained fewer or more then the regular 4 cone cells (Figure 2-5A). Most of the mutants 




from the fusion of two neighbouring ommatidia each having less than 4 cone cells (Figure 2-5BCD). 
According to this analysis, all newly recovered were characterized as hypomorphic as they are not as severe 
as the phenotype of a complete deletion of the entire hnt gene within Df(1)ED6727. Furthermore, 
immunostaining was performed on these alleles. Interestingly all were positive when using a polyclonal 
anti-Hnt serum. When using a monoclonal ant-Hnt antibody hntBHR49 and hntWN52 were monoclonal negative, 
polyclonal positive, this indicates that the overall structure of Hnt is mostly intact but certain epitopes have 
been altered (Figure 2-6CC’DD’). We also discovered that hntXE81, which was previously described as a 
null allele stained positive for the polyclonal anti-Hnt antibody (Figure 2-6E). When imaging embryos it 
was noted many of the alleles were recessive lethal and failed in germ band retraction (GBR) (Table 2-1). 
The process of GBR is an essential step in development and embryos that do not retract do not survive (Yip, 







hntWN29 ++ ++ retracted 
hntBHR28 + +++ tail-up 
hntBHR49 + +++ unretracted 
hntWN52 -   +* unretracted 
hntBHR5 + + unretracted 
hntBHR40 + +++ unretracted 
hntWN47 ++ +++ unretracted 
hntWN31 -   +* unretracted 
Df(1)ED6727 _ _ unretracted 
Table 2-1 Summary of Immunostaining results using anti-Hnt polyclonal and monocolonal 




Number of (+)’s indicates a qualitative amount of signal observed during immunostaining. A (–) indicates 
no signal during immunostaining. A tail-up phenotype indicates a partial retraction of the germ band. (*) 
Indicates that anti-Hnt signal was not localized to the nuclei. 
 
 




 (A) Ubi-DEcadherin-GFP expression in a control hntpeb/+ shows normal ommatidial structure with 4 cone 
cells per ommatidium. (B) hntpeb/hntpeb when raised at 25 shows some disruption in the number of 
ommatidia as highlighted by arrows. (C) hntpeb/Df(1)ED6727 shows both more and fewer cone cells in 
ommadidia. (D) hntpeb/hntWN47 with both more and fewer cone cells in ommatidia. (E) Comparing the 
number of abnormal ommatidia between wt, Df(1)ED6727 and the mutants in an allelic series. Scale bar 
represents 20µm. 
 
Figure 2-5 Immunostaining of Embryos using Both Hnt monoclonal and Polyclonal antibodies 
 (A-D) Represent anti-Hnt monoclonal staining. (A’-D’,E) Represent anti-Hnt polyclonal staining. (B,B’) 
hntWN29 shown with wt sib. Shows reduced anti-Hnt signaling in both polyclonal and monoclonal antibody. 
Oenocyte singal was observed in wt but not in hntWN29 as shown by arrows. (C, C’) hntBHR49 shows weak 
monoclonal signal but strong polyclonal. (D, D’) hntWN52 shows very weak signaling in monoclonal and 
slightly stronger non-nuclear signaling in polyclonal. (E) hntXE81 with degenerated amnioserosa showing 





We have shown that dCas9VPR based overexpression of a gene of interest can be used as a novel 
method to isolate new randomly induced mutation in a gene of interest. The same approach of using 
dCas9VPR mediated overexpression, however, is also a new tool for allele characterization. If the over-
expression phenotype associated with a previously identified mutant heterozygote (m/+) is less severe when 
compared to the overexpression phenotype of homozygous wildtype (+), two possibilities arise. First, the 
new allele might not be responsive to the over-expression system, in which case it could be refractory due 
to a naturally occurring polymorphism disrupting the guide target sequence. Second, the mutant allele may 
be associated with reduced expression or function for the GOI. Such loss-of-function alleles may be 
complete, known as nullomorphic alleles, or partial, in which case they are known as hypomorphic alleles. 
Barring the first possibility of disrupted gRNA target sequences, which can be ruled out by sequencing, the 
dCas9VPR system can be used to distinguish nullomorphic alleles from hypomorphic alleles. The expectation 
here is that the severity of the overexpression phenotype would relate to the total amount of gene function 
in the heterozygous overexpression background. That is, the overexpression phenotype of the heterozygous 
nullomorphic allele (mnull/+) would be less severe than the overexpression phenotype of the heterozygous 
hypomorphic allele (mhypo/+). This result is supported in the allelic series (Figure 2-5) where the deletion 
of the hnt region causes the most severe phenotype when compared to hntpeb which is considered a 
hypomorphic allele.   
In addition, the dCas9VPR mediated gene overexpression can be useful in determining if a particular 
mutant allele is capable of producing functional protein. If an allele for a GOI generates an overexpression 
phenotype that is indistinguishable from the homozygous wildtype, then it follows that this mutant allele is 




the coding sequence for the GOI. Several P element alleles of hnt, where the P element is inserted into a 
region 5’ to the TSS of hnt, were found to behave this way in our overexpression system.  
 As seen in Figure 2-4, when looking at the sequence data of the refractory alleles, 5 contain a 
deletion between guide regions. It was later discovered that all these lines originated from a single vial. 
These lines are identical so we can say that we really got 8 new hnt alleles and 3 refractory chromosomes.  
EMS mutagenesis is known to create small deletions so it is possible that EMS induced the mutation in a 
germline stem cell in the male (Ashburner, 1989). This would result in multiple sperm carrying the mutation 
whereas normally during EMS mutagenesis, only mature sperm are affected (Ashburner, 1989). These 
sperm then fertilized multiple eggs thus showing multiple copies of the same mutation. This is not 
uncommon in EMS screens and is generally referred to as a ‘pre-meiotic cluster’ (Ashburner, 1989). 
 Another explanation for the recovery of the five deletion mutants from one vial would be that there 
had been a spontaneous reversion of dCas9 to an active form in the female germline of one fly in the RGV 
line. This initially seems like a reasonable explanation due to how the small deletion perfectly encapsulates 
both target sites. However, multiple unlikely steps would have been needed for this to happen. The reverted 
dCas9 would have presented a refractory somatic phenotype due to the expression of the supposedly 
reverted dCas9. To make this heritable we would also have to assume that there had been leaky expression 
of reactivated dCas9 in the female germline from which the new refractory alleles were recovered. If this 
reversion event was the culprit, we would assume that it would happen at a much more frequent rate, but 
other experiments would refute this. In addition, this explanation does not explain how these deletions were 
clearly on chromosomes derived from the EMS treated males, which carry the [w+] transgene insertion 
e02388b which is tightly linked to the hnt locus. Overall, the most parsimonious explanation would be that 
EMS created a small deletion in the genome in the treated males. This chromosome, which was selected by 




to the other gRNA target sequence. Although EMS primarily produces GC to AT transitions, it is well 
known that EMS is quite effective at producing chromosome aberrations in Drosophila (Ashburner, 1989).  
Interestingly two of the refractory chromosomes contain mutations in the guide target sequences. 
The alleles hntWN72 and hntBHR7 contain mutations in the PAM and target sequence respectively (Figure 2-
4). Both alleles are refractory on their own which indicates that both guide targets are necessary for targeted 
overexpression.  
 All 8 of the new hnt alleles that were discovered had a very strong suppression phenotype and when 
re-tested, continued to show said phenotype. However, there were many supposed ‘hits’ that showed either 
intermediate phenotypes or strong phenotypes that did not show up again after re-testing. One possibility 
to explain these occurrences are mutations in dose-dependent second site modifiers. These modifiers could 
have been on any chromosome that was not the X. However, we were not able to isolate these second site 
modifiers due to the nature of the RGV line.  
It turns out that the RGV line used was not homozygous for the same refractory chromosome. The 
RGV line used contained 2 different variations of the refractory chromosome with subtle differences that 
may effect downstream applications. When crossing this RGV line to a known hnt mutation, it is possible 
to achieve an inconsistent result. A mixture of responsive and refractory results would be observed. 
Although both chromosomes are refractory, they gave subtly different response. These subtle responses 
would normally be how we would detect certain second site modifiers thus rendering this RGV 
chromosome useless for this application. We have since re-created the RGV line to include a homozygous 
hntWN35 as its refractory component. Thus, we are better able to identify second site modifiers in the future 
if this screen is repeated. 
 As mentioned, many “hits” did not breed true. The most likely explanation for this is that EMS is 




tissues of the eye but not the germline, and therefore the mutation would not be transmitted to the progeny 
of the selected female. When screening females we observed some inconsistency in the eye structure which 
would have been a result of genetic mosaicism. However, these inconsistencies were thought to be a reduced 
phenotype from hnt overexpression and were thus kept and re-tested. This later would prove false as they 
did not breed true.  
Through creating an allelic series (Figure 2-5E), we found that none of the new alleles gained were 
as potent as a true hnt deficiency. Although we did not expect that this would happen due to the single base 
pair change nature of EMS mutagenesis. Creating a small point mutation has a low chance of rending a 
protein completely unviable. Even so, we managed to create an array of hnt mutations that affected the 
resulting ommatidium with varying degrees of severity.  
 It is possible that this technique of selecting new mutants by screening F1 progeny for the lack of 
an overexpression phenotype can be used for other GOIs. There are several requirements that must be 
satisfied for this technique to become viable. First, a new gRNA must be created to target just upstream of 
the GOI for dCas9VPR to target the gene for over-expression. Second, the gene itself must have an over-
expression phenotype. Fortunately, due to how the technique is established the over-expression phenotype 
can be lethality. Third, a viable refractory chromosome must be created. If all of these criteria are met, then 
this technique can work for any GOI.  
 There are no other documented cases where a chromosome that is refractory to dCas9VPR-mediated 
over-expression has been created. Theoretically this should be a simple case of mutating the guide target 
sequences. As far as we know the ability to create this kind of chromosome may be the result of the inherent 
qualities of hnt. Until such a time when a new refractory chromosome has been created in another GOI we 




 The creation of the refractory chromosome relied heavily on the temperature sensitive dosage effect 
of hnt. However, it is possible that a single responsive copy of a GOI in the over expression background 
would produce lethality thus preventing the recovery of the refractory chromosome. One way to circumvent 
this would be to isolate a refractory chromosome over a deletion of a GOI. Another option may be to follow 
a similar crossing scheme as shown to achieve the refractory chromosome but reared at a lower temperature. 
As the Gal4 UAS system is temperature sensitive it is possible that reduced over-expression will not result 






Recovering CRISPR/Cas9 Induced Translocations using the “Dubinin 
Effect” 
3.1 Introduction 
One of the major advantages of CRISPR/Cas9 genome editing technology is ‘multiplexing’. 
Multiplexing is described as the ability to run multiple experiments concurrently in a single experiment 
(Lin et al., 2015). In some cases of CRISPR/Cas9 experiments this means adding multiple gRNAs to a 
model organism such that Cas9 will simultaneously make DSBs at multiple sites. The desired effect of this 
is to create mutations in more than 1 gene at a time (Chen et al., 2020). Multiplexing however, may result 
in undesirable chromosomal rearrangements (Chen et al., 2020). For some applications, however, the ability 
to recover chromosome rearrangements targeted to specific sites in the genome may be a desirable outcome. 
Such chromosomal rearrangements could be useful for studying aspects of gene regulation, or for creating 
novel rearrangements for the purpose of designing balancer chromosomes. The aim of the work presented 
in this chapter was to design a method of multiplexing in which the efficiency of inducing large scale 
chromosomal rearrangements could be determined.  
Being able to create targeted chromosomal rearrangements would be a ‘game changer’ for genetic 
research. If multiplexing different gRNAs to create desired DSBs caused large scale chromosomal 
rearrangements it could be used to build on the established toolbox of Drosophila genetics and allow for 
different tools to be adapted into other model organisms. Creating these rearrangements can also be used in 
other ways in Drosophila. For instance, if translocations can be produced, it is possible to translocate genes 
from their native regulatory regions. In this process larger and larger portions of the regulatory region could 
be translocated away from the downstream transcribed region to find where important regulatory elements 




There are multiple conventional ways to identify if a targeted chromosomal rearrangement has 
occurred. These include PCR and polytene squashes (Ashburner, 1989) but these methods can be difficult 
to do on larger scales. In order to establish the frequency at which these rearrangements happen, a faster, 
more efficient way of identifying when this event occurs is needed. For this purpose we took advantage of 
the Dubinin effect – which is a rather obscure and unusual bit of Drosophila genetics (Dubinin & Sidoroff, 
1934). This involves the gene Cubitus Interruptus (ci) and the mutant allele ci1. This allele is unusual in 
that it is normally recessive and is associated with a visible defect in the wing vein structure, but when 
homologue pairing is disrupted, ci1 becomes dominant – showing the same wing vein defect. By introducing 
a translocation in the region proximal to the gene ci, in theory it is possible to disrupt homologue paring 
and thus create a visible translocation marker when heterozygous to the ci1 allele (Dubinin & Sidoroff, 
1934). With this effect in mind, it is possible to quickly measure the rate at which translocations involving 
ci are recovered.  
Not only do we have Drosophila melanogaster as a model genetic organism, but researchers 
frequently study aspects of evolutionary and developmental biology using other Drosophila species. At 
present the genomes of 22 sister species of Drosophila have been sequenced and are viewable on FlyBase 
(Larkin et al., 2021). Researchers can compare conserved genome regions amongst different species of 
Drosophila with the aim of identifying sites- such as enhancer elements that regulate gene expression – that 
are likely functional in nature. Ultimately, using CRISPR/Cas9 technology, it is now theoretically possible 
to create mutations in a GOI in a sibling species identical to a mutation that has been studied and 
characterized in D. melanogaster. An interesting question would be to determine if the phenotype 
associated with a particular genetic lesion in D. melanogaster would present the same phenotype in a sibling 
species or if it would present a different phenotype. Overall, this would permit a better understanding of 




perform these types of experiments, some of the genetic tools that have been developed in D. melanogaster 
must be recreated in the sibling species. However, the genetic toolbox for these subspecies is limited. One 
of the largest hurdles in making a species suitable for different genetic testing is the inability to reliably 
keep alleles in stock. For this we would need to establish balancer chromosomes in these new species. In 
D. melanogaster balancer chromosomes have been painstakingly created over multiple decades, often 
through trial and error and often using random mutagenesis methods (Kaufman, 2017). However, the 
CRISPR/Cas9 system has been shown to be easily implemented in other model organisms. With this 
technology it should be much easier than before to create multiple inversions, and therefore balancer 
chromosomes in other species. It is therefore of general interest to determine the efficiency with which 
large chromosomal rearrangements can be recovered using CRISPR/Cas9 to simultaneously induce DSBs 
at two or more positions within the genome.   
3.1.1 Cubitus Interruptus 
Cubitus interruptus (ci) is a transcription factor involved in the hedgehog signaling pathway 
(Schwartz et al., 1995). This pathway is responsible for the proper formation of various organs. This 
pathway involves multiple segment polarity genes that are vital the proper formation of body segments and 
tissue type differentiation (Schwartz et al., 1995). Mutations in such genes can disrupt standard segment 
development and formation.  
 The wing imaginal disk of Drosophila can be divided into an anterior (A) and posterior (P) 
compartments (Ogden et al., 2004). P cells express engrailed (en) which signals P cells to express hedgehog 
(hh) (Ogden et al., 2004). After expressing Hh, P cells then become refractory to hh signaling. A cell can 
respond to hh signaling if it does not express en (Ogden et al., 2004). This creates a gradient in the imaginal 
disk allowing for the establishment of polarity. Response to Hh requires two genes smoothened (smo) and 




Ci[rep] and an activator form Ci[act]. When Hh is present Ci establishes as Ci[act] and when Hh is not present 
then Ci[rep] is formed (Ogden et al., 2004). Both interact with decapentaplegic (dpp) which is part of the 
transforming growth factor β (TGFβ) family (Ogden et al., 2004). This family activates genes in a 
concentration depended manner (Ogden et al., 2004). 
 The cubitus interruptus (ci) gene is located on chromosome 4 in D. melanogaster. Some mutants 
of ci homozygous viable and display a phenotype of a missing or disrupted L4 and/or L5 vein in the wing 
(Locke & Hanna, 1996). Strong loss of function alleles of ci are embryonic lethal. The ci1 allele is unusual 
in its behaviour. This is due to the observation that ci1 under some circumstances behaves as a recessive but 
in certain backgrounds it displays dominance (Dubinin & Sidoroff, 1934). The circumstance in which ci1 
behaves as a dominant allele is due to a transvection effect, where the normally recessive ci phenotype is 
presented in a dominant fashion due to the disruption of normal homologue pairing (Locke & Hanna, 1996). 
In other words, when heterozygous (ie ci1/+) and in the background of normal homologue pairing, the ci1 
allele behaves as a recessive. The same genotype in the background of a chromosomal rearrangement that 
disrupts pairing in the ci regulatory region has the effect of causing the ci1 allele to display a dominant 
phenotype (Locke & Hanna, 1996). This phenotype is caused by a pairing dependent repression of ci 
expression in the posterior compartment of the developing imaginal wing disk (Locke & Hanna, 1996). 
This effect has been used to recover translocations to the 4th chromosome (Ashburner, 1989). If 
there is a translocation event involving a breakpoint in proximity to the ci locus, it will result in a lack of 
pairing between the two homologous copies of ci and thus produce a broken wing vein (radius incompletes) 
phenotype (Ashburner, 1989).  
3.1.2 Translocations in other model organisms 
A translocation is a type of chromosomal rearrangement were sections of non-homologous 




lose various regulatory elements associated with the gene. This makes translocations a valuable tool to 
elucidate regulatory effects on various GOIs. The act of separating large sections of a chromosome 
physically can be used to analyze how various sections of that chromosome regulate GOIs. For instance, if 
a gene had a known large regulatory region, it is possible to separate that region from the GOI using a 
translocation. 
 The ability of CRISPR/Cas9 to create translocations in other model organisms is known. In 2019 
researchers managed to reshuffle yeast chromosomes using CRISPR/Cas9 ( Id et al, 2019). This experiment 
managed to randomly create fitness advantages under stressful growth conditions for the yeast (Id et al., 
2019). This was all in effort to better understand the physical relationships of various sections of DNA. In 
2016 new balancer chromosomes were engineered in C. elegans using CRISPR/Cas9. During these 
experiments it was discovered that translocations could also be made using CRISPR/Cas9 in C. elegans 
(Iwata et al., 2016).  
 In the past various forms of mutagens were used to induce translocations. These translocations 
would happen randomly and were very infrequent. Various other technologies to induce DSBs have been 
used to perform translocations in Drosophila. To-date CRISPR-Cas9 based translocations have not been 
observed.  
3.2 Methods 
3.2.1 Polytene Squash 
Female 3rd instar larvae were harvested and washed within distilled H2O. Each specimen was placed 
on a slide with a drop of 15% acetic acid solution. The salivary glands were removed and the remainder of 
the specimen was discarded. The acetic acid solution was blotted off and a drop of 1% orcein dye in 45% 
acetic acid solution (v/v) was added with a cover slip. The cover slip was gently slid back and forth to break 




the a pen to the top of the cover slip in order to distribute polytene chromosomes. Pressure was applied to 
the cover slip without sliding the cover slip in any direction. The preparation was then sealed with nail 
polish and visualized using phase contrast microscopy.   
3.2.2 Ci Screen 
The main objective of this screen was to determine if it is possible to efficiently recover large scale 
chromosomal rearrangements using a CRISPR-based approach. This was done by attempting to translocate 
the distal arm of the X chromosome that includes the region distal to hnt to the 4th chromosome proximal 
to the ci gene. For this experiment, we obtained gRNA transgenes that target upstream of ci as well as 
downstream to act as a negative control and used our existing TOE-GS00052 to induce DNA breaks within 
the upstream regulatory region of hnt. We collaborated with the Harvard Medical School - specifically the 
Drosophila RNAi Screening Center and Transgenic RNAi Project (DRSC/TRiP) on this project who 
created the TOE lines that target ci for this project. 
 We used Cas9 to simultaneously induce DSBs upstream of both hnt and ci.  At some frequency this 
should, in theory, induce a translocation. Taking advantage of the previously explained “Dubinin effect”, 
we then crossed the progeny to ci1 mutants. Progeny harbouring the desired translocation should produce a 
visible phenotype that disrupts development of the L4 or L5 vein. Such translocations can be easily verified 






Figure 3-1 Ci Screen Crossing Scheme 
Guides for both the hnt region (TOE-GS00052) and for the ci region (gci) were introduced in two separate 
instances using CyO and Tm3,Sb as markers respectively. The end result is that both of the guides were 
integrated into the same female that has the nosCas9 which allows for expression in the female germline. 
3.3 Results 
As shown in Table 2, after the crosses were complete, we managed to retrieve several progeny that 
when crossed to ci1 males, showed a dominant ci1 phenotype. These lines were all derived from the 
GP07436 guide line. These were then kept as lines and re-tested with ci1 to see if they bred true, which they 
did. However, when these lines were subjected to a polythene squash test, there was no evidence of a 










































Table 3-1 Summary of Translocation Screen Results 
Progeny were scored based on visible ci1 phenotype. GP07433 is located downstream of ci acting as a 





Unfortunately, no translocations were isolated using this technique. Although we recovered a ci11 
phenotype with a loss of the L5 wing vein (Table 3-1), based on their analysis by polytene squashes none 
contained a translocation event. In this discussion section I explore possible reasons why this method did 
not work as well as highlight different adjustments to the method that may lead this approach to produce 
translocations in the future. 
 As noted previously we did see ci1 phenotype progeny within the screen with the GP07436 guide. 
This was thought to be a positive result as a ci1 dominant phenotype would signal a translocation due to the 
Dubinin effect. However, this conclusion was proven to be false based on the polytene squash data. One 
possible explanation for this is that the Cas9 that was guided to the ci region ended up creating DSBs and 
mutating ci itself due to NHEJ. This mutation could have taken the form of a small deletion that would not 
be detectable from cytology. A significant deletion would disrupt pairing and thus give a ci1 phenotype. 
Ultimately, we decided not to pursue the exact reasoning for having a ci1 phenotype as it was abundantly 
clear that this method was not effective in creating large scale chromosomal rearrangements which was the 
overall goal of the experiment. 
 The nosCas9 used is supposed to work by expressing Cas9 in germline cells so that the progeny 
are transformed instead of producing Cas9 ubiquitously. This in theory allows us to introduce the two guides 
separately without any Cas9 activity taking place until both guides are added. Through other side projects 
within the lab we have discovered that the nosCas9 is somewhat leaky. This meaning that Cas9 is not 
localized to the germline of the progeny and thus has the ability to create DSBs outside of its intended 
niche. We theorize that when Cas9 is guided to a specific site eventually enough NHEJ will be done such 




time the second guide was added, the other site was sufficiently mutated, and no translocations could have 
taken place. 
 Another possibility is that the translocation we were aiming to create could be associated with a 
dominant lethal phenotype. When a translocation takes place, multiple regulatory elements may be 
separated from crucial genes. The mis-regulation of such genes could lead to lethality and therefore we 
would not see the translocation take place.  
 Although many translocations have been recovered by Drosophila researchers over the years 
(Larkin et al. 2021), these were for the most part induced randomly using ionizing radiation. In such screens 
there would be a selection for viable translocations. It is possible that only specific translocations are 
allowed in the Drosophila genome and such attempts to isolate others would prove impossible. If we are to 
explore the efficacy of using Cas9 to induce a translocation, the first step may be to try to precisely re-
create a known translocation. There are multiple translocations that take advantage of the Dubinin effect 
for screening. To create this, we would simply need replace the hnt guides for a guide that targets a known 
sight of translocation and keep the guide for ci the same.  
 Ultimately the reason we decided not to pursue this experiment any further in its current state was 
that the lack of any translocation in the number of samples taken would not be viable as a technique. The 
purpose of this experiment was to find a more efficient way to create translocations in a controlled manner. 
There are currently multiple ways to induce a translocation in the Drosophila system, however these 
techniques are extremely inefficient. The FRT based system is a way of creating translocations (Golic & 
Golic, 1996). FRT sites are placed randomly within the genome and using a FLPase these sites will be 
translocated with each other (Golic & Golic, 1996). An interesting possibility for designing large scale 
chromosome rearrangements would be to combine the CRISPR/Cas9 editing tool with the FRT site specific 




flanking the gRNA target site, FRT sites could be delivered to any site in the genome. Controlled and 




The goal of this thesis was to integrate CRISPR/Cas9 genome editing technology with traditional 
Drosophila genetic methods. The system of targeted gene overexpression using dCas9VPR was particularly 
effective for driving overexpression of our GOI, hnt. We found that this approach could be useful for 
characterizing existing alleles of hnt as nullomorphic alleles or hypomorphic alleles. We were also able to 
use this system design to design a novel genetic screen for the rapid recovery of new EMS-induced alleles 
as an F1 visible screen. The approach was successful and resulted in the recovery of 8 new hnt alleles. 
Three new refractory lines, lines whose only apparent phenotype was not being responsive to dCas9VPR 
mediated overexpression, were also recovered, and this was an expected side-effect of the screening 
strategy. A second set of experiments was aimed at the possibility of using CRISPR/Cas9 to recover large 
scale chromosomal rearrangements. Our strategy was to use a visible selection method to identify punitive 
translocations between the gene ci and hnt using what is known as the ‘Dubinin effect’. This approach was 
not successful. During the course of these studies other Drosophila researchers have also been developing 
new CRISPR/Cas9 based tools, some of which are described below and could be used towards achieving 
one of our original aims, which was the genetic dissection of the large upstream regulatory region of the 




4.1 Enhance NHEJ Pathway over HDR Pathway 
In order to create a chromosomal rearrangement, the NHEJ pathway must be utilized. When a DSB 
takes place the two methods of repair used are NHEJ and HDR. When HDR takes place, it is more likely 
that the DSB is repaired normally and no chromosomal rearrangement takes place (Min et al., 2004). If 
NHEJ is utilized however then two blunt ends are repaired together which is how a chromosomal 
arrangement would take place. 
 Manipulation of either of these pathways could impact the effectiveness of inducing translocations. 
The Ku70 gene has been shown to be involved in the NHEJ pathway (Min et al., 2004). By interfering in 
the production of Ku subunits it is possible to reduce repair normally done through the NHEJ pathway (Min 
et al., 2004). When this happens, we see an increase in large and small deletions within the chromosome 
indicating a decrease in repair efficiency.  
4.2 Large Regulatory Region 
Being able to induce translocations at will within a genome could aid the analysis of cis regulatory 
elements. An example would be to take a GOI and translocate it away with only parts of its regulatory 
region. By translocating larger and larger portions of the GOI and regulatory region, it may pinpoint which 
regions are important to the expression of the gene. If the GOI is translocated away from an important 
regulatory region we should see changes in its expression.  
A process has been created that serves a similar purpose called Cas9-mediated arrayed mutagenesis 
of individual offspring (CAMIO) (Chen et al., 2020). This is a CRISPR-based mutagenesis pipeline that 
creates multiple deletions in a genomic region of interest. Using an array of gRNA, it is possible to create 
multiple progeny with various deletions of different size (Chen et al., 2020). This is close to the effect that 




is that by translocating elements away from a GOI we can be sure that the element has an effect on the GOI 
based on its position.  
4.3 Balancers in Different Species 
Another use of this project is to create balancer chromosomes in other Drosophila species. The 
currently available balancer chromosomes were induced through ionizing radiation and therefore the 
inversion locations were random. Due to their random nature, these inversions take time to isolate. By 
inducing inversions using Cas9 we can make more targeted inversions which opens up possibilities for 
creating whole new lines of balancer chromosomes in Drosophila melanogaster. If the Cas9 system can be 
adapted to other Drosophila species, then we can induce inversions using this system. This process can be 
sped up using the Cas9 system to induce specific inversions thus cutting down the development time for 
creating a vital genetic tool in other species. 
 Balancer chromosomes can be used to keep recessive lethal mutations in stock. Establishing this 
vital genetic tool in other species will open doors for inter-species research. One application would be to 
see how a mutation in a GOI can affect behaviors in various species. Being able to keep these mutations 
balanced in a stock in multiple species would allow other researchers to compare the effects of a gene on a 
genus level rather than a species level.  
4.4 Insertion of FRT FLPase to Induce Inversions 
One interesting idea to induce inversions is to use the CRISPR/Cas9 system to insert two FRT site 
into the genome and then use FLP to create a chromosomal rearrangement. Originally discovered in yeast 
the FLP system was adapted to Drosophila in 1996 (Golic & Golic, 1996). In this paper, FRT sites are 
randomly added into the genome and FLP is used to cause a chromosomal rearrangement between these 
two sites(Golic & Golic, 1996). The main limitation of this technique was the reliance on randomly inserted 




a targeted fashion by creating a DSB at a target site and allowing an oligonucleotide with the desired FRT 
sequence to be integrated into the genome. This system has shown that two FRT sites when exposed to 
FLPase and being a few kilobases away has an almost 100% success rate (Golic & Golic, 1996). Increasing 
this distance to several kilobases still shows a success rate of a few percent (Golic & Golic, 1996).  
 Another possible method for FRT insertion is the newly adapted CRISPaint [CRISPR-assisted 
insertion tagging] (Bosch, Colbeth, Zirin, & Perrimon, 2020). This method involves two gRNA, one 
targeting a plasmid and the other targeting our genomic insertion site (Bosch et al., 2020). The plasmid we 
would use would contain an FRT site. In this system both guides are inserted with the plasmid and Cas9. 
This allows both gRNA targeted sites to undergo a DSB and through NHEJ, the plasmid would integrate 








Autosynaptic chromosomes are derived when a cytologically normal chromosome goes through 
recombination with a chromosome that contains a pericentric inversion (Ashburner, 1989). When these 
chromosomes segregate from each other, it normally results in a lethal amount of aneuploidy (Ashburner, 
1989). However a stock can be maintained if hereditary aneuploidy is compensated with a corresponding 
chromosome donated from the opposite parent. This stock is stable but can only be crossed with itself as 
the offspring with cytologically normal chromosomes will contain lethal amounts of aneuploidy 
(Ashburner, 1989). 
 By utilizing these stocks it is possible to create a screen where by the only possible viable progeny 
contain a new inversion. This new inversion would be in the autosynaptic form but it is possible through 
another crossover event to obtain a regular heterosynaptic chromosome. This is done by outcrossing 
autosynaptic females to cytologically normal males. 
Detecting the Presence of an Autosynpatic Inversion 
 In order to detect whether an autosynaptic inversion has taken place we have decided to use a PCR 
method. Two sets of primers were created flanking each of the two targeted cut sites. With a cytologically 
normal chromosome we would expect each set of primers to make products. However, if there is an 
inversion we expect the forward primer of one set to create a product with the reverse primer of the other 
(Figure 4-1). This is a simple technique to detect the presence of an inversion without doing any sequencing. 





Figure 4-1 Illustrating the use of mismatched primers to interpret inversion result 
Primers 2 and 3 flank a designated target site for Cas9 endonuclease activity. Primer 1 is a part of another 
set of primers designed for another target site on the same chromosome. (A) The result of a translocation 
where now 1 and 3 will produce a product where under normal circumstances they would not. (B) The 
result of a PCR involving a CRISPR induced allele (CIA-1) that has undergone an inversion and a 
wildtype control. In the wildtype control primers 1 and 3 do not create a product as they are too far away 







Figure 4-2 Showing inversion through sequencing data 
Targeted sites for Cas9 induced inversion are highlighted in yellow. Sites that were an inversion took 
place is highlighted by the black arrow. (A) Shows the 2L region at 39E3 and the section that is inverted 
away is highlighted in blue. (B) Reverse complement of the 2R region at 60C2. (C) Sequencing results 








2L 39E3 reference  sequence 






Primers used for sequencing guide region of refractory chromosome: 
 Hnt43-44InForw: 5’ – GGAGATTTGGTAGTCTGGCACA - 3’ 
 Hnt43-44InRev: 5’ – AGTTGGTTTCTTGAAGCGCC – 3’ 
Primers used for inversion detection: 
 Primer 1. 5’- CAGGCACCGACAAATAAGCG – 3’ 
 Primer 2. 5’- CGTTTCACCAACAGTACGGC – 3’ 
 Primer 3. 5’- TCAAATTTGCCGCTCTTGCC – 3’ 
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